FI902727A0 - Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi

Info

Publication number
FI902727A0
FI902727A0 FI902727A FI902727A FI902727A0 FI 902727 A0 FI902727 A0 FI 902727A0 FI 902727 A FI902727 A FI 902727A FI 902727 A FI902727 A FI 902727A FI 902727 A0 FI902727 A0 FI 902727A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
chromane derivatives
chromane
derivatives
Prior art date
Application number
FI902727A
Other languages
English (en)
Swedish (sv)
Other versions
FI95701C (fi
FI95701B (fi
Inventor
Rolf Gericke
Manfred Baumgarth
Ingeborg Lues
Rolf Bergmann
Peyer Jacques De
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of FI902727A0 publication Critical patent/FI902727A0/fi
Application granted granted Critical
Publication of FI95701B publication Critical patent/FI95701B/fi
Publication of FI95701C publication Critical patent/FI95701C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI902727A 1989-06-02 1990-06-01 Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi FI95701C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918041A DE3918041A1 (de) 1989-06-02 1989-06-02 Chromanderivate

Publications (3)

Publication Number Publication Date
FI902727A0 true FI902727A0 (fi) 1990-06-01
FI95701B FI95701B (fi) 1995-11-30
FI95701C FI95701C (fi) 1996-03-11

Family

ID=6381944

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902727A FI95701C (fi) 1989-06-02 1990-06-01 Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi

Country Status (20)

Country Link
US (1) US5112972A (fi)
EP (1) EP0400430B1 (fi)
JP (1) JPH0320275A (fi)
KR (1) KR910000713A (fi)
AR (1) AR245715A1 (fi)
AT (1) ATE110072T1 (fi)
AU (1) AU623780B2 (fi)
CA (1) CA2017961A1 (fi)
DE (2) DE3918041A1 (fi)
DK (1) DK0400430T3 (fi)
ES (1) ES2057262T3 (fi)
FI (1) FI95701C (fi)
HU (1) HUT58323A (fi)
IE (1) IE65098B1 (fi)
IL (1) IL94256A (fi)
NO (1) NO175976C (fi)
NZ (1) NZ233912A (fi)
PT (1) PT94225B (fi)
TW (1) TW210338B (fi)
ZA (1) ZA904227B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
WO1995013272A1 (fr) 1993-11-10 1995-05-18 Japan Tobacco Inc. Derive de chromanne et utilisation therapeutique de ce dernier
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6677371B1 (en) * 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
CN100337624C (zh) 2002-11-12 2007-09-19 沃纳-兰伯特公司 使用苯并吡喃类化合物促进毛发生长的方法
EP1836183A2 (en) * 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
CA2620846A1 (en) * 2005-09-01 2007-03-08 Janssen Pharmaceutica N.V. Benzopyran and pyranopyridine derivatives as potassium channel openers
WO2024040267A2 (en) * 2022-08-19 2024-02-22 Mitokinin, Inc. Direct synthesis of n-(3-substituted-chroman-4-yl)-7h- pyrrolo[2,3-d]pyrimidin-4-amines and derivatives thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
EP0091748B1 (en) * 1982-04-08 1986-06-18 Beecham Group Plc Antihypertensive benzopyranols
EP0093534A1 (en) * 1982-04-28 1983-11-09 Beecham Group Plc Novel chromanols
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate

Also Published As

Publication number Publication date
IE65098B1 (en) 1995-10-04
NZ233912A (en) 1992-10-28
DK0400430T3 (da) 1994-09-12
EP0400430B1 (de) 1994-08-17
AU623780B2 (en) 1992-05-21
EP0400430A2 (de) 1990-12-05
EP0400430A3 (de) 1991-01-02
AR245715A1 (es) 1994-02-28
NO902459D0 (no) 1990-06-01
ES2057262T3 (es) 1994-10-16
HU903293D0 (en) 1990-10-28
FI95701C (fi) 1996-03-11
ZA904227B (en) 1991-03-27
US5112972A (en) 1992-05-12
CA2017961A1 (en) 1990-12-02
IE901988A1 (en) 1991-01-02
DE3918041A1 (de) 1990-12-06
PT94225B (pt) 1996-12-31
FI95701B (fi) 1995-11-30
DE59006817D1 (de) 1994-09-22
IE901988L (en) 1990-12-02
JPH0320275A (ja) 1991-01-29
NO902459L (no) 1990-12-03
AU5600790A (en) 1990-12-06
IL94256A0 (en) 1991-03-10
NO175976B (no) 1994-10-03
NO175976C (no) 1995-01-11
HUT58323A (en) 1992-02-28
TW210338B (fi) 1993-08-01
IL94256A (en) 1994-04-12
PT94225A (pt) 1991-02-08
ATE110072T1 (de) 1994-09-15
KR910000713A (ko) 1991-01-30

Similar Documents

Publication Publication Date Title
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI892182A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI95704B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI903737A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pentafluorietyyli-substituoitujen valiini- tai fenyylialaniinijohdannaisten valmistamiseksi
FI905941A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI884910A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI890283A (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI903863A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI903704A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI94351B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI901606A0 (fi) Tieno-triatsolo-diatsepiinien sulfonyylijohdosten valmistusmenetelmä
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUN